MedPath

Comparison of the effects of Ketamine and Propofol and Dexmedetomidine in treatment with electroconvulsive therapy in patients with depressio

Phase 3
Recruiting
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20141209020258N143
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

18 to 60 years
Both sexes
Patients with a diagnosis of schizophrenia

Exclusion Criteria

No history of drug use
No pregnancy
No history of cardiovascular disease (arrhythmias, ischemia, heart block)
Do not take beta-blockers
There are no contraindications to ECT, such as spinal cord injury and high ICP, and recent heart attacks.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Every 5 minutes. Method of measurement: Counting.;Mean blood pressure. Timepoint: Every 5 minutes. Method of measurement: Barometer.;Seizure duration. Timepoint: In times of seizures. Method of measurement: Minutes.;Patient satisfaction. Timepoint: After the shock. Method of measurement: Satisfaction Questionnaire.;Recovery duration. Timepoint: After the shock. Method of measurement: Minute.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath